The hypercoagulable states.

Area of Science:

• Hematology
• Clinical Medicine
• Pathophysiology

Background:

• Hypercoagulable states are conditions with laboratory abnormalities or clinical factors increasing thrombosis risk.
• These states are categorized as primary (inherited defects in anticoagulant mechanisms) or secondary (acquired disorders linked to systemic diseases).
• Recognized primary states include antithrombin III deficiency, protein C and S deficiencies, fibrinolytic system abnormalities, and dysfibrinogenemias.

Purpose of the Study:

• To define and differentiate primary and secondary hypercoagulable states.
• To discuss the pathophysiology of secondary hypercoagulable states.
• To provide a framework for laboratory investigation and clinical approach to patients with hypercoagulable states.

Main Methods:

• Review of existing literature on hypercoagulable states.
• Classification of hypercoagulable states into primary and secondary categories.
• Discussion of pathophysiologic features and diagnostic approaches.

Main Results:

• Growing recognition of specific primary hypercoagulable states, often due to defective physiologic anticoagulant mechanisms.
• Identification of common secondary hypercoagulable states associated with malignancy, pregnancy, oral contraceptives, myeloproliferative disorders, hyperlipidemia, diabetes, and vascular/rheologic abnormalities.
• Emphasis on the complex pathophysiology of secondary states.

Conclusions:

• Hypercoagulable states represent a spectrum of inherited and acquired conditions predisposing to thrombosis.
• A systematic approach integrating laboratory findings and clinical assessment is essential for managing patients.
• Further understanding of pathophysiology aids in developing targeted diagnostic and therapeutic strategies.